IRIS

Paclobutrazol

CASRN 76738-62-0

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (7 pp, 87 K) last updated: 03/31/1987

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Hepatic 1.3 x 10-2 Elevated liver weights, serum cholesterol, hepatic aminopyrine N-demethylase activity, and alanine transaminase levels NOEL : 1.25 x 101
mg/kg-day
1000 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (7 pp, 87 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (7 pp, 87 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (7 pp, 87 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (7 pp, 87 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.